PRO_1170x120_4-1-19

Walgreens Boots Alliance

Fred’s: Deal to buy Rite Aid stores still in effect

Fred’s: Deal to buy Rite Aid stores still in effect

MEMPHIS, Tenn. — Fred’s Inc. has reaffirmed its $950 million deal to buy 865 Rite Aid stores to be divested for antitrust clearance of Walgreens Boots Alliance’s pending acquisition of Rite Aid Corp. Fred’s said late Monday that “the asset purchase agreement it entered into on Dec. 19, 2016, with Walgreens and Rite Aid remains

Stefano Pessina: Rite Aid deal talks ‘ongoing’

Stefano Pessina: Rite Aid deal talks ‘ongoing’

NEW YORK — Walgreens Boots Alliance (WBA) is still negotiating with the Federal Trade Commission to gain antitrust clearance for its $17 billion deal to acquire Rite Aid Corp., WBA executive vice chairman and chief executive officer Stefano Pessina said at the company’s annual shareholders meeting. “The FTC is doing its job. The process is

Walgreens Boots Alliance results mixed in 1Q

Walgreens Boots Alliance results mixed in 1Q

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) edged past Wall Street’s adjusted earnings per share forecast in its fiscal 2017 first quarter despite declined sales and net income. WBA also reported Thursday that it’s still working to finalize its $17 billion deal to acquire Rite Aid Corp. and continues to expect to complete the transaction

Fred’s adopts ‘poison pill’ plan

Fred’s adopts ‘poison pill’ plan

MEMPHIS, Tenn. — Fred’s Inc. has adopted a shareholder rights plan, also known as a “poison pill,” after a hedge fund recently became the company’s single largest shareholder. Fred’s said Tuesday its board instituted the shareholder rights plan after observing “unusual and substantial activity in the company’s shares.” The discount and pharmacy retailer noted that

Rite Aid sales, earnings decline in Q3

Rite Aid sales, earnings decline in Q3

CAMP HILL, Pa. — Rite Aid Corp. said slim reimbursement rates, new generic drugs and the ongoing antitrust talks for the merger with Walgreens Boots Alliance (WBA) squeezed sales and earnings for its fiscal 2017 third quarter. Rite Aid said Thursday that for the third quarter ended Nov. 26, sales dipped 0.8% to $8.09 billion

WBA beats Wall Street’s 4Q, full-year earnings forecast

WBA beats Wall Street’s 4Q, full-year earnings forecast

DEERFIELD, Ill. — As talks roll on to gain regulatory clearance for its acquisition of Rite Aid Corp., Walgreens Boots Alliance (WBA) posted adjusted earnings for its fiscal 2016 fourth quarter and full year that topped Wall Street’s estimates. WBA said Thursday that GAAP net earnings attributable to Walgreens Boots Alliance totaled $1.03 billion, or

WBA ups store sell-off estimate for Rite Aid deal

WBA ups store sell-off estimate for Rite Aid deal

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) said it’s working on store divestiture scenarios with the Federal Trade Commission to gain clearance for its $17.2 billion deal to acquire Rite Aid Corp. WBA said Thursday that it and Rite Aid “remain actively engaged” in talks with the FTC as the regulator reviews the acquisition, which

Walgreens Boots Alliance posts 3Q gains

Walgreens Boots Alliance posts 3Q gains

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) saw sales and adjusted net earnings rise in its fiscal 2016 third quarter, with adjusted earnings per share exceeding Wall Street’s consensus forecast. WBA said Wednesday that its pending acquisition of Rite Aid Corp. remains on track for completion in the second half of this year, and it

Rivals make each other better

Rivals make each other better

Only days — or weeks — may remain until Walgreens Boots Alliance’s long-delayed acquisition of Rite Aid gets the go-ahead from the Federal Trade Commission. If and when that clearance comes, Rite Aid will officially become part of WBA, and the competition between the Walgreens and CVS Pharmacy drug chains will finally take form so

Rite Aid turns in net loss for first quarter

Rite Aid turns in net loss for first quarter

CAMP HILL, Pa. — Rite Aid Corp. cited pressure in pharmacy reimbursement as it reported a net loss and fell short of Wall Street’s earnings forecast for its fiscal 2017 first quarter. Meanwhile, overall retail sales and same-store sales edged up for the quarter, and the EnvisionRx pharmacy benefit management business, acquired about a year